Company: INCR
Filing Date: 2025-05-01
Form Type: 20-F
Source: 0001641172-25-007971
Chunk: 212

Company: Intercure Ltd.
Filing Date: 2025-05-01
Form: 20-F
Item: Item 18
Chunk 212
---
2023, respectively.
 
 
F-61
----
Note 24 - Operating Segments:
 
Operating segments are reported according to the same basis of internal reports that are regularly reviewed by the Company’s Chief Operating Decision Maker, who is responsible for allocating resource to the Company’s operating segments and assessing their performance.
 
The Company has 2 operating segments: (A) Investments in portfolio companies in the biomed sector, and (B) Investments in the medical cannabis sector.
 

A.                                           Investments                                        
     in portfolio companies in the biomed sector: the Company has investments in XTL, Cavnox and
       Fore. These investments are measured at fair value through profit or loss. See Note 11.  
------------------------------------------------------------------------------------------------
 
Presented below are financial data regarding the segment:
  Schedule of Financial Data Regarding Segment
 
                                     2024                2023         
----------------------------------------------------------------------
                                                  NIS in thousands    
Loss from investment in XTL              116                    22    
Loss from investment in Cavnox             -                   965    
Gain from investment                     225                  (322   )
in Fore                                                               
Gain                                     341                   665    
(Loss) from investment                                                

                                              2024                   2023     
------------------------------------------------------------------------------
                                                              NIS in thousands
Fair value of the investment in XTL                 250                    134
Fair value of the investment in Cavnox                -                      -
Fair value of the investment in Fore              2,147                  1,922
Fair                                              2,397                  2,056
value of the investment                                                       

B.                                             Investments                                           
     in the medical cannabis sector: Canndoc, Cannolam, Pharmazone and other investments as described
         in Note 8. The Company’s Chief Operating Decision Maker (the CEO) reviews the financial     
                                    results as a single business unit.                               
-----------------------------------------------------------------------------------------------------

F-62
----
Note 24 - Operating Segments: (Cont.)
 
Operating segment data:
 
Reconciliation of operating segment data include addition of assets and liabilities which were not attributed to segments.
 
 Schedule of Operating Segments
 
                                                                   NIS in thousands                                                                                      
                                                                   Cannabis segment              Biomed segment              Reconciliations             Total           
Year ended December 31, 2024                                                                                                                                             
External revenue                                                              238,845                      -                           -                      238,845    
Segment profit (loss)                                                         (39,697    )       341                                   -                      (39,356   )
                                                                                                                                       -                                 
General and administrative expenses not attributable to